Back to Featured
OpenAI: Website updates2026-10-20 08:0028 days ago

OpenAI acquires drug development platform Orchestra Bio and integrates it into the Rosalind life sciences system

OpenAI acquires Orchestra Bio

AI Briefing

OpenAI announces the acquisition of Orchestra Bio, a platform that helps biopharmaceutical teams coordinate the complex processes involved in drug development. Its team and technology will be integrated with Rosalind. Orchestra's agents can help teams track research and project progress, analyze the impact of events such as failed production batches on clinical trial timelines, and propose responses. The article also mentions collaborations with Novo Nordisk and Moderna, as well as the background that new drug development takes an average of 10 to 15 years.

Reported by 6 additional sources

Source: OpenAI: Official Website Updates · openai.com

Finished reading the news? Let’s talk about your business.

Leave your contact details, and I’ll get in touch with you personally.

WECHAT

Add me on WeChat

Press and hold or select the WeChat ID below to copy it.